Genvor’s Antimicrobial Peptides Advance into Sugar Beet Research

About this update from Genvor Incorporated

Woodland, CA, July 27, 2026 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR) ("Genvor"), a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health, today announced that its proprietary antimicrobial peptides are being evaluated for their potential to address microbial challenges in sugar beet production, storage, and processing. The research is being conducted under the ARS Sustainable Sugar Beet Research Initiative, with Genvor serving as a collaborator contributing its antimicrobial peptides for evaluation. The project focuses on the development and evaluation of antimicrobial peptide technologies for agriculture, with the goal of advancing peptide-based approaches to crop protection, including work aimed at improving crop resilience and reducing microbial threats in major agricultural systems. "This research reflects the practical value of translating years of peptide research into potentially real agricultural opportunities," said Dr. George Stavrides, Executive Vice President, Business Development & Commercialization at Genvor. "Sugar beet production is a meaningful new area where Genvor's antimicrobial peptides can support growers, processors, and the broader agricultural value chain." The sugar beet project extends that work into an additional high-value crop sector. Microbial activity during storage and processing can reduce sugar recovery, product quality, and operational efficiency. Through this collaboration, USDA-ARS researchers will evaluate whether Genvor's antimicrobial peptides can inhibit key microbes involved in sugar beet root rot and in downstream sugar extraction, with the goal of supporting more efficient and sustainable sugar beet production. "Our work with collaborators has consistently demonstrated how much peptide science can contribute to agriculture," said Dr. Jesse Jaynes, Co-Founder of Genvor and the founding scientist behind the company's core peptide technologies. "Extending that collaboration into sugar beet lets us apply our peptides to a new set of microbial targets and continue advancing the design work that makes these tools more effective." The collaboration is expected to generate research data that may inform future peptide-based strategies for crop protection, post-harvest quality, and processing efficiency. About Genvor Genvor, In...

View stock analysis, news, and events for Genvor Incorporated